Journal article
From APOBEC to ZAP: Diverse mechanisms used by cellular restriction factors to inhibit virus infections
Biochimica et biophysica acta. Molecular cell research, Vol.1866(3), pp.382-394
03/2019
DOI: 10.1016/j.bbamcr.2018.09.012
PMCID: PMC6334645
PMID: 30290238
Abstract
Antiviral restriction factors are cellular proteins that inhibit the entry, replication, or spread of viruses. These proteins are critical components of the innate immune system and function to limit the severity and host range of virus infections. Here we review the current knowledge on the mechanisms of action of several restriction factors that affect multiple viruses at distinct stages of their life cycles. For example, APOBEC3G deaminates cytosines to hypermutate reverse transcribed viral DNA; IFITM3 alters membranes to inhibit virus membrane fusion; MXA/B oligomerize on viral protein complexes to inhibit virus replication; SAMHD1 decreases dNTP intracellular concentrations to prevent reverse transcription of retrovirus genomes; tetherin prevents release of budding virions from cells; Viperin catalyzes formation of a nucleoside analogue that inhibits viral RNA polymerases; and ZAP binds virus RNAs to target them for degradation. We also discuss countermeasures employed by specific viruses against these restriction factors, and mention secondary functions of several of these factors in modulating immune responses. These important examples highlight the diverse strategies cells have evolved to combat virus infections.
•Cellular restriction factors utilize diverse mechanisms to inhibit virus infections.•Restriction factors utilize both enzymatic and non-enzymatic mechanisms.•Viruses are inhibited at numerous stages of their life cycles by restriction factors.•Viruses often encode proteins that counteract restriction factors.•Many restriction factors serve dual roles as immunomodulators.
Details
- Title: Subtitle
- From APOBEC to ZAP: Diverse mechanisms used by cellular restriction factors to inhibit virus infections
- Creators
- Mahesh Chemudupati - Department of Microbial Infection and Immunity, The Ohio State University, Columbus, OH, USAAdam D Kenney - Department of Microbial Infection and Immunity, The Ohio State University, Columbus, OH, USASerena Bonifati - Department of Veterinary Biosciences, The Ohio State University, Columbus, OH, USAAshley Zani - Department of Microbial Infection and Immunity, The Ohio State University, Columbus, OH, USATemet M McMichael - Department of Microbial Infection and Immunity, The Ohio State University, Columbus, OH, USALi Wu - Department of Microbial Infection and Immunity, The Ohio State University, Columbus, OH, USAJacob S Yount - Department of Microbial Infection and Immunity, The Ohio State University, Columbus, OH, USA
- Resource Type
- Journal article
- Publication Details
- Biochimica et biophysica acta. Molecular cell research, Vol.1866(3), pp.382-394
- DOI
- 10.1016/j.bbamcr.2018.09.012
- PMID
- 30290238
- PMCID
- PMC6334645
- NLM abbreviation
- Biochim Biophys Acta Mol Cell Res
- ISSN
- 0167-4889
- eISSN
- 1879-2596
- Publisher
- Elsevier B.V
- Grant note
- DOI: 10.13039/100000002, name: NIH, award: AI130110, AI104483
- Language
- English
- Date published
- 03/2019
- Academic Unit
- Microbiology and Immunology
- Record Identifier
- 9984001111202771
Metrics
19 Record Views